Transposagen, Janssen to Develop Chimeric Antigen Receptor T-Cell Therapies

News   Nov 26, 2014

 
Transposagen, Janssen to Develop Chimeric Antigen Receptor T-Cell Therapies
 
 
 

RELATED ARTICLES

Boosting the Power of Cancer-killing T-cells

News

CRISPR-edited T-cells could be a thousand times better at seeing and killing cancer than T-cells prepared using the current methodology.

READ MORE

New Cell-weighing Technique Helps Predict How Drugs Affect Cancer Cells

News

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.

READ MORE

Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological Aging

News

The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE